Furthermore, Ling et al., 2022 reported a significant binding affinity of the bioactive compound celastrol towards nasopharyngeal carcinoma (NPC) targets, namely, IL6, VEGFA, and TNF. The gene discussed is TNF; the disease is nasopharyngeal carcinoma.